Press Releases

GlobeNewswire, Inc.

Boston, May 05, 2026 (GLOBE NEWSWIRE) -- Major technology companies are investing $650 billion annually in artificial intelligence infrastructure as enterprise AI adoption surges from 22% in 2025 to an expected 40% by 2026, according to BCC...

GlobeNewswire, Inc.

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- 7AI, the company whose customers trust dynamic AI agents to get security work done at scale, today announced it has been named to CB Insights’ tenth annual AI 100, showcasing the 100 most promising private...

GlobeNewswire, Inc.

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Ataccama, the data trust company, today announced a partnership with ServiceNow, the AI control tower for business reinvention, to embed data quality signals directly into enterprise workflows, ensuring AI...

GlobeNewswire, Inc.

PETACH-TIKVA, Israel, May 05, 2026 (GLOBE NEWSWIRE) -- Discure Technologies, a clinical-stage medical device company pioneering treatments for degenerative disc disease and other orthopedic disorders, today announced the appointment of Ray Baker,...

GlobeNewswire, Inc.

KT-579 demonstrated activity comparable or superior to approved and clinically active therapies in preclinical IBD models KT-579 Phase 1 healthy volunteer trial ongoing, with data expected in 2H26 WATERTOWN, Mass., May 05, 2026 (GLOBE NEWSWIRE) --...

GlobeNewswire, Inc.

- Abstract from trial evaluating Alpha DaRT® in combination with pembrolizumab in elderly patients with locally advanced and metastatic head and neck squamous cell carcinoma selected for podium presentation - - The AHNS International Conference on...

GlobeNewswire, Inc.

SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene” or the “Company”) and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late clinical-stage biopharmaceutical company focused...

GlobeNewswire, Inc.

NASHVILLE, Tenn., April 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2026. In addition, the Company announced an increased 2026 Normalized FFO guidance...

GlobeNewswire, Inc.

PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026. First Quarter...

GlobeNewswire, Inc.

BOSTON, April 30, 2026 (GLOBE NEWSWIRE) -- On April 26, 30 students and six chaperones from the Boston area returned from Panama after a week spent finishing two new classrooms, painting four murals, and refurbishing two playgrounds, working...

GlobeNewswire, Inc.

VANCOUVER, British Columbia and BOSTON, MA, May 01, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of...

GlobeNewswire, Inc.

Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural changes and inflammation in the esophagus in adult patients with EoE at week 24 compared to placebo, in...

GlobeNewswire, Inc.

As recently announced, tovecimig (DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement in progression-free survival (PFS) versus paclitaxel alone as well as clear signals of...

Office of the Attorney General California Department of Justice

California expected to receive over $440 million from the settlement OAKLAND — California Attorney General Rob Bonta today announced that a $7.4 billion settlement previously reached with Purdue Pharma and its owners, the Sackler family, has...

GlobeNewswire, Inc.

BASEL, Switzerland and BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Noema Pharma AG today announced the presentation of Phase 2a study results evaluating cendifensine in menopausal women experiencing moderate-to-severe vasomotor symptoms (VMS) in a...

GlobeNewswire, Inc.

Press release - No. 9 / 2026 The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting Camilla Sylvest will bring deep commercial expertise to the Board at a...

GlobeNewswire, Inc.

Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...

Missouri Attorney General

Missouri to receive more than $91 million JEFFERSON CITY, Mo. — Today, Attorney General Catherine Hanaway announced that a $7.4 billion settlement reached with Purdue Pharma and its owners, the Sackler family, has become legally effective.

GlobeNewswire, Inc.

-- First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity -- -- European Commission grants authorization in adults and children 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or...

EIN Presswire

Next 8 Weeks Will Be A Pivotal Test For Apartment Demand BOSTON, MA, UNITED STATES, April 29, 2026 /⁨EINPresswire.com⁩/ -- Boston Pads, the industry leader in tracking real-time rental market data in Boston, reports that Boston’s citywide...